- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03128671
Family Automated Voice Reorientation Study (FAVoR)
November 5, 2021 updated by: Cindy Munro, University of Miami
Reorientation Intervention for Delirium in ICU
This randomized clinical trial tests a cognitive reorientation intervention to prevent delirium in the intensive care unit using scripted audio messages, recorded by the patient's family and played at hourly intervals during daytime hours, to provide information about the ICU environment to the patient (the Family Automated Voice Reorientation intervention, FAVoR).
The investigators hypothesize that providing ongoing orientation to the ICU environment through recorded audio messages in a voice familiar to the patient will enable the patient to more accurately interpret the environment and reduce risk of delirium.
Increasing awareness of daytime by cuing patients during waking hours may also improve day/night orientation, nighttime sleep/rest, and further reduce risk of delirium.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This randomized clinical trial will test the effectiveness of a nonpharmacologic intervention to prevent delirium in the intensive care unit (ICU), which affects as many as 80% of critically ill, mechanically ventilated adults..
The Family Automated Voice Reorientation (FAVoR) intervention uses scripted audio messages, recorded by the patient's family and played at hourly intervals during daytime hours, to provide information about the ICU environment to the patient; this ongoing orientation to the ICU environment through recorded messages in a voice familiar to the patient may enable the patient to more accurately interpret the environment and thus reduce risk of delirium.
Increasing awareness of daytime by cuing patients during waking hours may also improve day/night orientation and nighttime sleep, further reducing risk of delirium.
The primary specific aim of the project is to test the effect of the FAVoR intervention on delirium in critically ill, mechanically ventilated adults during hospitalization in the ICU.
Secondary aims are to: (1) explore if the effect of FAVoR on delirium is mediated by sleep, (2) explore if selected biobehavioral factors may potentially moderate the effects of FAVoR on delirium, and (3) examine the effects of FAVoR on short term (immediately after ICU discharge) and long term (1 and 6 months after hospital discharge) outcomes, including cognitive function and patient-reported health status.
Study Type
Interventional
Enrollment (Actual)
178
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136-1003
- University of Miami UHealth Tower
-
Miami, Florida, United States, 33136-1005
- Jackson Memorial Hospital
-
Tampa, Florida, United States, 33606
- Tampa General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- mechanically ventilated patients
- within 36 hours of ICU admission
- patient or legally authorized representative (LAR) must be able to provide informed consent in English or Spanish
- a family member able to speak English or Spanish must be available and willing to audio record scripted messages
Exclusion Criteria:
- dementia (because it complicates planned longitudinal cognitive assessments)
- anticipation by the clinical provider of imminent patient death
- medical contraindication to the intervention (for example, psychiatric history of auditory hallucinations, or profoundly deaf)
- inability to speak either English or Spanish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FAVoR Intervention Group
In the intervention group, scripted audio messages recorded by the patient's family (FAVoR intervention) will be played for the patient at hourly intervals during daytime hours.
These messages will be personalized, delivered automatically, and provide information about the ICU environment.
The FAVoR intervention, a standardized protocol developed and tested in preliminary work, will be delivered by audio recording for 5 consecutive days (120 hours), or until ICU discharge if discharge occurs within the first 5 days.
The number of episodes of delirium during ICU stay is the primary outcome measure.
Data will also be collected at 1 month and 6 months following hospital discharge for secondary aim 3.
|
The FAVoR intervention includes a set of 8 scripted recorded messages, no longer than 2 minutes long, includes subject's name, uses simple terms, and is written at a 5th grade reading level.
Messages include information about the critical care environment, the visual and auditory stimuli to be expected, and the availability of providers and family.
|
|
No Intervention: Control Group
The control group will not receive the FAVoR intervention.
The number of episodes of delirium during ICU stay is the primary outcome measure.
Data will also be collected at 1 month and 6 months following hospital discharge for secondary aim 3.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Delirium-free Days
Time Frame: Up to 20 days in the intensive care unit (ICU)
|
Delirium will be assessed by study personnel, blinded to the group assignment, using Confusion Assessment Method-Intensive Care Unit (CAM-ICU)
|
Up to 20 days in the intensive care unit (ICU)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep
Time Frame: Up to 5 days in the ICU
|
Sleep Profiler polysomnography
|
Up to 5 days in the ICU
|
|
Cognitive Function
Time Frame: At least 24 hours post ICU discharge, 1 month post hospital discharge, & 6 months post hospital discharge
|
NIH Cognitive Toolbox measures
|
At least 24 hours post ICU discharge, 1 month post hospital discharge, & 6 months post hospital discharge
|
|
Patient-reported Health Status
Time Frame: At least 24 hours post ICU discharge, 1 month post hospital discharge, & 6 months post hospital discharge
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scales
|
At least 24 hours post ICU discharge, 1 month post hospital discharge, & 6 months post hospital discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cindy L Munro, PhD, University of South Florida
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 19, 2017
Primary Completion (Actual)
November 6, 2020
Study Completion (Actual)
May 17, 2021
Study Registration Dates
First Submitted
April 11, 2017
First Submitted That Met QC Criteria
April 20, 2017
First Posted (Actual)
April 25, 2017
Study Record Updates
Last Update Posted (Actual)
December 3, 2021
Last Update Submitted That Met QC Criteria
November 5, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20170771
- Pro00027039 (Other Identifier: USF IRB)
- R01NR016702 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Alexandria UniversityCompletedClozapine Poisoning | Hypoactive Delirium | Tricyclic Antidepressant Poisoning | Anticholinergic Delirium | Antipsychotic Toxicity | CNS Depression | Procyclidine Induced DeliriumEgypt
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Duke UniversityNot yet recruitingDelirium Confusional State | Hyperactive Delirium | Delirium in the Intensive Care Unit | Agitated DeliriumUnited States
-
Universitat de LleidaHospital d'IgualadaNot yet recruitingDelirium in Old Age | Delirium Treatment | Delirium Confusional StateSpain
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicCompletedDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Wonkwang University HospitalCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityAffiliated Wenling Hospital of Wenzhou Medical UniversityRecruitingInjection | Delirium in Old Age | Post Operative Delirium | Non-cardiac SurgeryChina
Clinical Trials on FAVoR Intervention
-
Tel Hai CollegeBar-Ilan University, IsraelCompleted
-
Tel Hai CollegeEnrolling by invitationPrimary PreventionIsrael
-
Tel Hai CollegeCompleted
-
Tel Hai CollegeEnrolling by invitation
-
Tel Hai CollegeCompletedPrimary PreventionIsrael
-
Tel Hai CollegeRecruitingPreventive TherapyIsrael
-
Prisma Health-UpstateFAVOR (Faces and Voices of Recovery) OF GREENVILLE; South Carolina Department...CompletedOpioid-use Disorder | Opiate Overdose | Opiate AbuseUnited States
-
ProMedica Health SystemUnknown
-
Mahidol UniversityCompletedNausea and Vomiting, PostoperativeThailand
-
VA Pharmacy Benefits Management Strategic Healthcare...CompletedHypertensionUnited States